Home Articles & Issues Editor's Picks Collections Videos For Authors Journal Info
Skip Navigation LinksHome > Collections > Belatacept Mediated Costimulation Blockade

Belatacept Mediated Costimulation Blockade

Creator:   K J Wood
Created:   2/16/2011
Contains:  18 items

Actions
View

An Integrated Safety Profile Analysis of Belatacept in Kidney Transplant Recipients

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

Belatacept-Based Regimens Versus a Cyclosporine A-Based Regimen in Kidney Transplant Recipients: 2-Year Results From the BENEFIT and BENEFIT-EXT Studies

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

Islet Transplantation in Type 1 Diabetic Patients Using Calcineurin Inhibitor-Free Immunosuppressive Protocols Based on T-Cell Adhesion or Costimulation Blockade

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

Low Serum Mannose-Binding Lectin as a Risk Factor for New Onset Diabetes Mellitus After Renal Transplantation

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

Belatacept as Immunosuppression in Patient With Recurrence of Hemolytic Uremic Syndrome After Renal Transplantation

Purchase Access
PDF
+ Favorites
Request Permissions

Assessment of Belatacept-Mediated Costimulation Blockade Through Evaluation of CD80/86-Receptor Saturation

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

Fibrogenesis in Kidney Transplantation: Potential Targets for Prevention and Therapy

Purchase Access
Abstract
PDF
+ Favorites
Request Permissions

A Mixed Treatment Comparison of Efficacy and Cardiometabolic Safety of Belatacept, Cyclosporine and Tacrolimus for Immunosuppression Therapy in Adult Renal Transplant Recipients:...

Free Access
PDF
+ Favorites
Request Permissions

Outcomes As A Function of Donor:Recipient Characteristics From A Phase III Study of Belatacept Vs Cyclosporine in Kidney Transplantation (Benefit): 2857

Free Access
PDF
+ Favorites
Request Permissions

Safety Profile of Belatacept in Kidney Transplant Recipients From A Pooled Analysis of Phase II and Phase III Studies: 1417

Free Access
PDF
+ Favorites
Request Permissions

Immunosuppression With Belatacept-Based, Cni-Avoiding and Steroid-Avoiding Regimens Vs A Tacrolimus-Based, Steroid-Avoiding Regimen in Kidney Transplant Patients: Results of A...

Free Access
PDF
+ Favorites
Request Permissions

Switch From A Cni- to A Belatacept-Based Immunosuppressive Regimen in Kidney Transplant Recipients Is Safe and Results in Better Renal Function: 12 Month Results From A Phase II...

Free Access
PDF
+ Favorites
Request Permissions

Belatacept Vs Cyclosporine in Kidney Transplant Recipients: Two-Year Outcomes From the Benefit Study: 1374

Free Access
PDF
+ Favorites
Request Permissions

Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Belatacept in Renal Transplant Patients: 1870

Free Access
PDF
+ Favorites
Request Permissions

Application of A Validated Long-Term Renal Transplant Graft Survival Prediction Model to Expected Belatacept Phase III Trial Outcomes: 679

Free Access
PDF
+ Favorites
Request Permissions

Relationship Between Belatacept Exposure and Clinical Endpoints in Renal Transplant Patients: 1892

Free Access
PDF
+ Favorites
Request Permissions

Outcomes As A Function of Donor Criteria From A Phase III Study of Belatacept Vs Cyclosporine in Kidney Transplantation (Benefit-Ext): 1773

Free Access
PDF
+ Favorites
Request Permissions

Benefit-Risk Profile of the Belatacept Li Regimen At 2 Years in Ebv(+) Kidney Transplant Recipients: 3370

Free Access
PDF
+ Favorites
Request Permissions
Actions
View
Collection Alerts

Stay up-to-date! Be notified every time a new item is added. Receive an Email or subscribe to an RSS feed.